FMR LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:16 am Sale | 2024-02-08 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FMR LLC | 50,970 0.147% | -1,260,032 (-96.11%) | Filing |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FMR LLC | 1,311,002 5.325% | 299,502 (+29.61%) | Filing |